Page 8 - Eric Lenze News Today

email article Since the early days of the pandemic, researchers have been trying to use old drugs for new tricks, raising hopes and spurring controversy. Some of these, like hydroxychloroquine, turned out to be flops, while others are still debated. Recently, another old drug called fluvoxamine has come onto the scene. MedPage Today explores how the old antidepressant has made its way to the COVID spotlight. Fluvoxamine and the COVID Early Treatment Fund Fluvoxamine is the poster child o...

Courtesy of Steve Kirsch Los Altos Hills resident Steve Kirsch funded research into the drug fluvoxamine as a treatment for COVID-19. So far, doctors have failed to share his sense of urgency. Steve Kirsch is baffled. He’s discovered a common medication that’s highly effective in minimizing the impacts of COVID-19 – two studies have proven so. But the mainstream medical community refuses to acknowledge its efficacy pending a third, much larger trial that would involve 1,100 participants a...

The race to find vaccines for COVID-19 has dominated the headlines, but theres been less news about how to keep people with COVID out of the hospital. Tonight, were going to tell you a story about one possible treatment. Its called fluvoxamine. The generic drug was developed 40 years ago as an antidepressant and has been primarily used to treat obsessive-compulsive disorder. Now, a small but ingenious clinical trial and a series of coincidences have led scientists to look closely at fluvoxamine...

What Is Fluvoxamine? OCD Drug Could Be Used to Treat COVID On 3/8/21 at 9:49 AM EST An anti-depressant medication used to treat obsessive-compulsive disorder (OCD) may also be effective at treating some COVID cases, scientists say. The drug fluvoxamine, commonly sold under the brand name Luvox, has emerged as a candidate for early treatment of the disease, with studies suggesting it could prevent some peoples symptoms progressing to the point of needing hospitalization. Fluvoxamine is a type of...

Small Study Suggests Antidepressant Fluvoxamine Could Treat COVID-19 Silvia Pittman © The Mighty Medication capsule on blue background An antidepressant already on the market could pave the way toward more affordable and accessible treatment for people with a symptomatic COVID-19 infection. A new clinical trial using the psychiatric drug fluvoxamine (brand name Luvox) showed promise in a Washington University trial in reducing serious outcomes for people with the virus. Resea...

Scientists are researching the potential role a common antidepressant called fluvoxamine could play in preventing severe illness and lung damage in COVID-19 patients.

Early last year, Angela Reiersen, a psychiatrist at Washington University in St. Louis, took ill with what she suspected was COVID-19. Because of a shortage of tests at the time, she never found out for sure, and she recovered before long. But the experience got her thinking about something. Reiersen had recently seen research suggesting that an antidepressant called fluvoxamine was useful in treating sepsis, a potentially fatal condition in which the body releases a dangerous imbalance of chem...

Share this article Share this article BERKELEY, Calif., Jan. 15, 2021 /PRNewswire/ -- The COVID-19 Early Treatment Fund (CETF) announced today that the use of the generic antidepressant fluvoxamine helped speed the recovery of dozens of COVID-infected workers at Golden Gate Fields, the Berkeley horse racing venue that reopened Friday. The track physician, Dr. David Seftel, offered fluvoxamine to infected employees after learning about the 100% success rate in avoiding hospitalization in a Phase...

Matt Miller William G. Powderly, MD, discusses COVID-19 cases with staff in the intensive care unit at Barnes-Jewish Hospital. Powderly says that although vaccine development has been rapid, the search for therapies for patients infected with the novel coronavirus has been less successful. A new episode of our podcast, “Show Me the Science,” has been posted. At present, these podcast episodes are highlighting research and patient care on the Washington University Medical Campus as our scien...